Biomerica, Inc. announced that the American Medical Association's CPT editorial panel has granted a Proprietary Laboratory Analysis (PLA) code for its inFoods® IBS test, which personalizes the ...
Biomerica, Inc. (Nasdaq: BMRA), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced that an abstract evaluating the real-world clinical ...
Gastro Health, a leading gastroenterology group, plans to utilize this simplified blood collection method when recommending the inFoods ® IBS to their patients Biomerica (BMRA) also announced that ...
Biomerica, Inc. has announced that a landmark peer-reviewed study published in the June 2025 issue of Gastroenterology shows the inFoods® IBS test is an effective personalized dietary therapy for ...
An elimination diet guided by a novel irritable bowel syndrome (IBS)–specific immunoglobulin G (IgG) assay reduced abdominal pain in a greater proportion of patients with IBS than a sham elimination ...
The expert panel agreed that the VAS-IBS gives a good picture of how a patient with IBS might feel, and all members except one thought that the VAS-IBS might be useful in clinical practice. Agreement ...
inFoods IBS showed improvement in API similar to, and in some cases better than, current IBS drugs in the market NEWPORT BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results